539 related articles for article (PubMed ID: 12051707)
21. Lentivector-mediated RNAi efficiently suppresses prion protein and prolongs survival of scrapie-infected mice.
Pfeifer A; Eigenbrod S; Al-Khadra S; Hofmann A; Mitteregger G; Moser M; Bertsch U; Kretzschmar H
J Clin Invest; 2006 Dec; 116(12):3204-10. PubMed ID: 17143329
[TBL] [Abstract][Full Text] [Related]
22. Efficient lymphoreticular prion propagation requires PrP(c) in stromal and hematopoietic cells.
Kaeser PS; Klein MA; Schwarz P; Aguzzi A
J Virol; 2001 Aug; 75(15):7097-106. PubMed ID: 11435590
[TBL] [Abstract][Full Text] [Related]
23. Transcriptional modulation in a leukocyte-depleted splenic cell population during prion disease.
Huzarewich RL; Medina S; Robertson C; Parchaliuk D; Booth SA
J Toxicol Environ Health A; 2011; 74(22-24):1504-20. PubMed ID: 22043911
[TBL] [Abstract][Full Text] [Related]
24. Prions in skeletal muscle.
Bosque PJ; Ryou C; Telling G; Peretz D; Legname G; DeArmond SJ; Prusiner SB
Proc Natl Acad Sci U S A; 2002 Mar; 99(6):3812-7. PubMed ID: 11904434
[TBL] [Abstract][Full Text] [Related]
25. Molecular genetics of human prion diseases.
Collinge J; Palmer MS
Philos Trans R Soc Lond B Biol Sci; 1994 Mar; 343(1306):371-8. PubMed ID: 7913754
[TBL] [Abstract][Full Text] [Related]
26. Emergence of two prion subtypes in ovine PrP transgenic mice infected with human MM2-cortical Creutzfeldt-Jakob disease prions.
Chapuis J; Moudjou M; Reine F; Herzog L; Jaumain E; Chapuis C; Quadrio I; Boulliat J; Perret-Liaudet A; Dron M; Laude H; Rezaei H; Béringue V
Acta Neuropathol Commun; 2016 Feb; 4():10. PubMed ID: 26847207
[TBL] [Abstract][Full Text] [Related]
27. Insights into prion strains and neurotoxicity.
Aguzzi A; Heikenwalder M; Polymenidou M
Nat Rev Mol Cell Biol; 2007 Jul; 8(7):552-61. PubMed ID: 17585315
[TBL] [Abstract][Full Text] [Related]
28. Variant Creutzfeldt-Jakob disease: immunocytochemical studies and image analysis.
Nailon WH; Ironside JW
Microsc Res Tech; 2000 Jul; 50(1):2-9. PubMed ID: 10871542
[TBL] [Abstract][Full Text] [Related]
29. B lymphocyte-restricted expression of prion protein does not enable prion replication in prion protein knockout mice.
Montrasio F; Cozzio A; Flechsig E; Rossi D; Klein MA; Rülicke T; Raeber AJ; Vosshenrich CA; Proft J; Aguzzi A; Weissmann C
Proc Natl Acad Sci U S A; 2001 Mar; 98(7):4034-7. PubMed ID: 11274428
[TBL] [Abstract][Full Text] [Related]
30. Complement facilitates early prion pathogenesis.
Klein MA; Kaeser PS; Schwarz P; Weyd H; Xenarios I; Zinkernagel RM; Carroll MC; Verbeek JS; Botto M; Walport MJ; Molina H; Kalinke U; Acha-Orbea H; Aguzzi A
Nat Med; 2001 Apr; 7(4):488-92. PubMed ID: 11283678
[TBL] [Abstract][Full Text] [Related]
31. Generation of cell lines propagating infectious prions and the isolation and characterization of cell-derived exosomes.
Vella LJ; Hill AF
Methods Mol Biol; 2008; 459():69-82. PubMed ID: 18576148
[TBL] [Abstract][Full Text] [Related]
32. [Neuropathological diagnosis of prion disease].
Murayama S; Saito Y; Hatsuta H; Sakiyama Y
Nihon Rinsho; 2007 Aug; 65(8):1401-6. PubMed ID: 17695276
[TBL] [Abstract][Full Text] [Related]
33. Octapeptide repeat region of prion protein (PrP) is required at an early stage for production of abnormal prion protein in PrP-deficient neuronal cell line.
Sakudo A; Wu G; Onodera T; Ikuta K
Biochem Biophys Res Commun; 2008 Jan; 365(1):164-9. PubMed ID: 17981146
[TBL] [Abstract][Full Text] [Related]
34. Correlative studies support lipid peroxidation is linked to PrP(res) propagation as an early primary pathogenic event in prion disease.
Brazier MW; Lewis V; Ciccotosto GD; Klug GM; Lawson VA; Cappai R; Ironside JW; Masters CL; Hill AF; White AR; Collins S
Brain Res Bull; 2006 Jan; 68(5):346-54. PubMed ID: 16377442
[TBL] [Abstract][Full Text] [Related]
35. Role of the CD8+ dendritic cell subset in transmission of prions.
Sethi S; Kerksiek KM; Brocker T; Kretzschmar H
J Virol; 2007 May; 81(9):4877-80. PubMed ID: 17301133
[TBL] [Abstract][Full Text] [Related]
36. Prion infectivity in variant Creutzfeldt-Jakob disease rectum.
Wadsworth JD; Joiner S; Fox K; Linehan JM; Desbruslais M; Brandner S; Asante EA; Collinge J
Gut; 2007 Jan; 56(1):90-4. PubMed ID: 16763054
[TBL] [Abstract][Full Text] [Related]
37. A novel copper-hydrogen peroxide formulation for prion decontamination.
Solassol J; Pastore M; Crozet C; Perrier V; Lehmann S
J Infect Dis; 2006 Sep; 194(6):865-9. PubMed ID: 16941355
[TBL] [Abstract][Full Text] [Related]
38. Pall leukotrap affinity prion-reduction filter removes exogenous infectious prions and endogenous infectivity from red cell concentrates.
Sowemimo-Coker SO; Pesci S; Andrade F; Kim A; Kascsak RB; Kascsak RJ; Meeker C; Carp R
Vox Sang; 2006 May; 90(4):265-75. PubMed ID: 16635068
[TBL] [Abstract][Full Text] [Related]
39. Development of oligomeric prion-protein aggregates in a mouse model of prion disease.
Sasaki K; Minaki H; Iwaki T
J Pathol; 2009 Sep; 219(1):123-30. PubMed ID: 19479969
[TBL] [Abstract][Full Text] [Related]
40. Measuring prions causing bovine spongiform encephalopathy or chronic wasting disease by immunoassays and transgenic mice.
Safar JG; Scott M; Monaghan J; Deering C; Didorenko S; Vergara J; Ball H; Legname G; Leclerc E; Solforosi L; Serban H; Groth D; Burton DR; Prusiner SB; Williamson RA
Nat Biotechnol; 2002 Nov; 20(11):1147-50. PubMed ID: 12389035
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
